Updates are available Correction dated 2024-01-17
Click to view Correction: https://doi.org/10.1038/s41572-024-00493-2
-
Authors
Mocumbi, Ana http://orcid.org/0000-0002-9564-2860
Humbert, Marc http://orcid.org/0000-0003-0703-2892
Saxena, Anita
Jing, Zhi-Cheng http://orcid.org/0000-0003-0493-0929
Sliwa, Karen
Thienemann, Friedrich http://orcid.org/0000-0002-4801-2030
Archer, Stephen L.
Stewart, Simon http://orcid.org/0000-0001-9032-8998
- License Information
-
More Information
Article History
Accepted: 27 November 2023
First Online: 4 January 2024
Change Date: 17 January 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41572-024-00493-2
Competing interests
: M.H. declares institutional, speaker, consultant or steering committee fees from Aerovate, Altavant, AOP Orphan, Bayer, Ferrer, Janssen (Actelion), MSD (Acceleron) and United Therapeutics. The other authors declare no competing interests.
